Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
Oreterra Announces Closing of Final Tranche of $9.7 Million Oversubscribed and Upsized Non-Brokered Private Placement
SAGA Metals Reports Assay Intercepts Including 52.05% Fe?O?, 7.21% TiO?, 0.375% V?O? from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
